Navigation Links
Pharmacyclics Announces Subscription Price for Rights Offering
Date:7/15/2009

s listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us athttp://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our expectations and beliefs regarding our future results or performance. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements. Additionally, you should not consider past results to be an indication of our future performance. For a discussion of the risk factors and other factors that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law.


'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
2. Pharmacyclics Files Registration Statement for Rights Offering
3. Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
4. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
5. Pharmacyclics Secures $5.0 Million in Debt Financing
6. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
7. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
8. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
9. Pharmacyclics Announces It Received Nasdaq Notification
10. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
11. Blue Marble Energy Corp. Announces Successful Close of Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... Biofuels will present at CleanEquity Monaco 2015 on March 5th ... . Logo - http://photos.prnewswire.com/prnh/20141114/158674LOGO ... by Innovator Capital, the London based ... Prince Albert II of Monaco,s ... Monte-Carlo SBM, Oceanographic Museum of Monaco , ...
(Date:11/15/2014)... Nov. 14, 2014  F. David Rollo , ... Who as a Pinnacle Professional in the field of ... of Cell Point, LLC. Cell Point is ... Centennial, Colorado , Houston ... company,s five technology platforms, ethylenedicysteine drug conjugate technology ("EC ...
(Date:11/12/2014)... Research Labs (a registered trade name of ReachBio LLC, ... it has signed an agreement with Funakoshi Co., Ltd. ... distribution rights to ReachBio,s human primary cell product line ... Japan . Under a companion agreement, Funakoshi will ... drug development companies. Photo - http://photos.prnewswire.com/prnh/20141111/157946LOGO ...
(Date:11/12/2014)... (PRWEB) November 11, 2014 ... and one year of achieving GMP compliance with ... clearly defined and impressive blueprint for creating high ... and Requisition process and ending with the final ... where each product is in the process,” explains ...
Breaking Biology Technology:Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3Innovative Formulations Achieves GMP Compliance and Success with InstantGMP™ MES 2
... , ... #1 Worldwide Market Position in Automated QT Studies , ... Rochester, New York (PRWEB) October 8, 2009 -- ... analysis, announced today that an international pharmaceutical company has awarded iCardiac a comprehensive cardiac ...
... , PITTSBURGH, Oct. 7 Today the National ... launch of BMEStart, an award recognizing undergraduate excellence ... NCIIA,s other biomedical competition (BMEidea) because of its ... as much experience with product development. , ...
... , NEW YORK, Oct. 7 /PRNewswire-FirstCall/ - Healthnostics, ... analytics company, announced today details regarding the social ... re-design. Using the Facebook(C) model that gives individuals ... build an interactive layer that allows users to ...
Cached Biology Technology:Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 2NCIIA Announces New Undergraduate Competition 2Healthnostics' Medbioworld.com Portal Web Site to Include Social Networking Features 2
(Date:11/3/2014)... Researchers from Australia report that low birth weight and ... (OA)-related hip replacements in adulthood. Findings published in the ... & Research , indicate that low birth weight and ... arthroplasty due to OA as adults. , According ... of 25 are diagnosed with clinical OA. Symptoms of ...
(Date:11/2/2014)... it was fascinating to put a flashlight up to ... hand. Washington University in St. Louis engineers are using ... tissues to improve imaging of cancerous tissues and to ... Gene K. Beare Distinguished Professor of Biomedical Engineering at ... a novel time-reversal technology that allows researchers to better ...
(Date:10/31/2014)... In the early 1900s, Brazil was the world,s largest ... were cultivated in a 800, 000 ha region of ... canopy of native shade trees. Whereas the surrounding rainforest ... derived mainly from a handful of seeds introduced in ... variation. According to Brazilian scientist Gonçalo Pereira, "This scenario ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2Improving imaging of cancerous tissues by reversing time 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 3
... Researchers with the Faculty of Medicine & Dentistry ... "protective" T-cells can kill neurons. This finding is significant ... touted in the medical community as a potential treatment ... Giuliani and his post-doctoral fellow, Yohannes Haile, both from ...
... partner La Nia, the warm and cold phases in the ... worldwide. Predicting El Nio events more than several months ahead ... a warming world has been hampered by the short instrumental ... that annually resolved tree-ring records from North America, particularly from ...
... May 6, 2011 According to the United States Department ... in restaurants. As it is widely known, food prepared ... is often higher in calories, saturated fat, and sodium. ... May/June 2011 issue of the Journal of Nutrition Education ...
Cached Biology News:Discovery demonstrates potential MS therapy could kill brain cells 2Tree rings tell a 1,100-year history of El Niño 2Families are 'lovin' it' 2
... selection system for recombinant identification. Recombinant selection ... need for costly color screening. This quick ... accuracy in recombinant selection. pLivSelect is also ... This cloning kit can be used for ...
... antibiotic-based selection system for recombinant identification. Recombinant ... the need for costly color screening. This ... 100% accuracy in recombinant selection. pLivSelect is ... picking. This cloning kit can be used ...
... 96-well semi-skirted PCR plate, Directly compatible with ... Flat deck for improved sealing characteristics ... seals, mats or cap strips, Certified free ... We are part of Thermo Fisher Scientific, ...
...
Biology Products: